Morepen Laboratories Limited has informed the Exchange about Newspaper Publication of the Financial Results for the quarter ended June 30, 2025
MOREPENLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Morepen Laboratories Limited has published its unaudited Q1 FY26 financial results (quarter ended June 30, 2025) in Financial Express and Jansatta newspapers on August 7, 2025, after Board approval on August 6, 2025. On a consolidated basis, total income from operations fell to ₹42,523.88 lakhs from ₹45,521.57 lakhs in the year-ago quarter. Net profit after tax dropped sharply to ₹1,140.66 lakhs from ₹3,616.79 lakhs, a decline of about 68% year-on-year. Consolidated EPS fell to ₹0.20 from ₹0.71. On a standalone basis, total income from operations rose modestly to ₹39,128.43 lakhs from ₹38,564.32 lakhs, but net profit after tax declined to ₹806.12 lakhs from ₹3,504.96 lakhs, a drop of about 77% year-on-year. The full results are available on NSE, BSE, and the company's website.
Sharp year-on-year decline in profits on both consolidated and standalone bases, with consolidated net profit falling ~68% and standalone net profit falling ~77%, could weigh negatively on investor sentiment. However, this is a routine regulatory newspaper publication of already-approved results, so the immediate stock reaction may be limited.